Reproductive gene editing imperils universal human rights
By Marcy Darnovsky, Leah Lowthorp, and Katie Hasson,
OpenGlobalRights
| 02. 15. 2018
What do recent advances in molecular genetics have to do with human rights? Quite a lot, it turns out. And key human rights documents have recognized this for some time.
Over the past few years, new “gene editing” tools that are cheaper, easier to use, and more accurate than previous ways to change living organisms’ DNA have rapidly spread to labs around the world. Scenarios that previously seemed far-fetched or far off now confront us, including the prospect of directly controlling the genes and traits that are passed down to future children and generations. Since 2015, a half dozen research teams, in China, the UK, and the United States, have separately reported efforts to modify specific genes in human embryos. These developments have brought us to a critical juncture: human reproductive gene editing now poses a threat to the human rights of future generations.
Gene editing for human reproduction carries huge social risks. It has the potential to threaten the health and autonomy of future generations, to exacerbate existing social disparities, and to lay the basis for a new market-based...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
By Emily Mullin, Wired | 10.30.2025
In 2018, Chinese scientist He Jiankui shocked the world when he revealed that he had created the first gene-edited babies. Using Crispr, he tweaked the genes of three human embryos in an attempt to make them immune to HIV and...